USE OF GHOST NANOVESICLES AS THERAPEUTICS
The present disclosure provides ghost nanovesicles (gNVs) that are deficient in cytosolic components. Methods of making such vesicles and therapeutic uses of such vesicles are also provided. The gNVs may be used in preventing or treating conditions that may benefit from administration of the gNVs. S...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
19.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides ghost nanovesicles (gNVs) that are deficient in cytosolic components. Methods of making such vesicles and therapeutic uses of such vesicles are also provided. The gNVs may be used in preventing or treating conditions that may benefit from administration of the gNVs. Such conditions include conditions that involve inflammation. |
---|---|
Bibliography: | Application Number: EP20200863703 |